Search - tctmd.com

Displaying 41 - 60 of 1006

Sort: Relevancy | Date

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

Presenter: Michaella Alexandrou

October 30, 2024

Presentation TCT 2024

COUNTERPOINT: The Surgical Standard Will Predominate!

Presenter: Michael Bowdish

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Presentation TCT 2024

Between Pressure and Volume: Right Heart Physiology in TR

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Presenter: Michael Morgan

October 29, 2024

Presentation TCT 2024

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Presenter: Michael Brener

October 29, 2024

Presentation TCT 2024

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

Presenter: Michael Young

October 29, 2024

Presentation TCT 2024

My Personal Guide to Prevention and Management of Equipment Disasters

Presenter: R. Michael Wyman

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Diabetes and Obesity: Modulating Cardiometabolic Risks

Presenter: C. Michael Gibson

October 28, 2024

Advertisement

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

TCT 754: Native Coronary Artery Instead of Saphenous Vein Graft Intervention for Treatment of Significant Saphenous Vein Graft Lesions (“NASA” Registry)

COUNTERPOINT: The Surgical Standard Will Predominate!

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 308: Colchicine for the Prevention of Recurrent Non-Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Between Pressure and Volume: Right Heart Physiology in TR

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

TCT 1419: Ascending Aortic Pseudoaneurysm Seven Years After TAVR and Seventeen Years After SAVR

Case 3: TR in the Setting of Advanced LV Dysfunction – Finding the Sweet Spot

Case-Based Examples – Primary MR, Green Zone Anatomy (Including Optimizing the Transseptal Puncture)

My Personal Guide to Prevention and Management of Equipment Disasters

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Diabetes and Obesity: Modulating Cardiometabolic Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content